Oaklins Smith & Williamson has advised the shareholders of QMS Medicosmetics GmbH, a leading premium skin care brand, on the sale of the company to BlueGem Capital Partners LLP.
This transaction reflects an increase in private equity and venture capital activity in the luxury end of the sector.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.